Cargando…

The Role of the Research Advanced Practice Provider in CAR T-Cell Clinical Trials

In recent years, chimeric antigen receptor (CAR) T-cell therapy has emerged as an effective and potentially paradigm-shifting therapy for patients with refractory lymphoma and myeloma. This novel therapy involves engineering T cells to recognize specific antigens on the surface of cancer cells. Seve...

Descripción completa

Detalles Bibliográficos
Autor principal:	Dsouza, Ly
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press LLC 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894206/ https://www.ncbi.nlm.nih.gov/pubmed/36741214 http://dx.doi.org/10.6004/jadpro.2023.14.1.5

Ejemplares similares

An Advanced Practice Provider Guide to Peripheral Nerve Stimulation
por: Hoffmann, Chelsey M, et al.
Publicado: (2022)

Role of the Advanced Practice Provider in Clinical Trials: Contributions to the Management of Patients Receiving Inotuzumab Ozogamicin
por: Welch, Mary Alma, et al.
Publicado: (2017)

The Role of Advanced Practice Providers and Telemedicine in Reinventing Care: The Transition of a CAR T-Cell Transplantation Program to the Outpatient Setting
por: LeBar, Kiersten, et al.
Publicado: (2020)

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Kulemzin, Sergey, et al.
Publicado: (2021)

Supportive Care for Patients with Lymphoma Undergoing CAR-T-cell Therapy: the Advanced Practice Provider’s Perspective
por: Granroth, Ginna, et al.
Publicado: (2022)

Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemia
por: Zhao, Juanjuan, et al.
Publicado: (2019)

Overview of approved CAR‐T therapies, ongoing clinical trials, and its impact on clinical practice
por: Sengsayadeth, Salyka, et al.
Publicado: (2021)

Recent advances in CAR-T cell engineering
por: Huang, Ruihao, et al.
Publicado: (2020)

Recent Advances in Allogeneic CAR-T Cells
por: Kim, Dong Wook, et al.
Publicado: (2020)

The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice
por: Cerrano, Marco, et al.
Publicado: (2020)

Chimeric Antigen Receptor beyond CAR-T Cells
por: Qin, Vicky Mengfei, et al.
Publicado: (2021)

Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
por: Hawkins, Elizabeth R, et al.
Publicado: (2021)

Practical issues in CAR T-cell therapy
por: Byun, Ja Min
Publicado: (2023)

Understanding the Role of Advanced Practice Providers in Oncology in the United States
por: Bruinooge, Suanna S., et al.
Publicado: (2018)

CAR-T Cell Therapy for Breast Cancer: From Basic Research to Clinical Application
por: Yang, Yu-Huan, et al.
Publicado: (2022)

Clinical trials of CAR-T cells in China
por: Liu, Bingshan, et al.
Publicado: (2017)

Pharmaceutical Clinical Educators: A Resource for Advanced Practice Providers
por: Arrington, Sheila Adams, et al.
Publicado: (2018)

Recent updates on CAR T clinical trials for multiple myeloma
por: Lin, Quande, et al.
Publicado: (2019)

Tracking the CAR-T Revolution: Analysis of Clinical Trials of CAR-T and TCR-T Therapies for the Treatment of Cancer (1997–2020)
por: Ivica, Nikola A., et al.
Publicado: (2021)

Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
por: Albinger, Nawid, et al.
Publicado: (2021)

Current updates on generations, approvals, and clinical trials of CAR T-cell therapy
por: Asmamaw Dejenie, Tadesse, et al.
Publicado: (2022)

CAR T cell therapy in solid tumors: A review of current clinical trials
por: Patel, Urvi, et al.
Publicado: (2021)

CAR T-cell therapy for B-cell lymphomas: clinical trial results of available products
por: Chavez, Julio C., et al.
Publicado: (2019)

Hematopoietic stem cell transplantation-associated thrombotic microangiopathy and the role of advanced practice providers and pharmacists
por: Mahmoudjafari, Zahra, et al.
Publicado: (2023)

Cars, CONSORT 2010, and Clinical Practice
por: Williams, Hywel C
Publicado: (2010)

Role of CAR T Cell Metabolism for Therapeutic Efficacy
por: Rial Saborido, Judit, et al.
Publicado: (2022)

Recent advances in CAR T-cell therapy for lymphoma in China
por: Che, Yuxuan, et al.
Publicado: (2023)

Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors
por: Boccalatte, Francesco, et al.
Publicado: (2022)

Advances in CAR-T Cell Therapy in Head and Neck Squamous Cell Carcinoma
por: Wang, Han-Qi, et al.
Publicado: (2023)

Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies
por: Huang, Shengkang, et al.
Publicado: (2023)

Advances in CAR T Cell Therapy for Non-Small Cell Lung Cancer
por: Ma, Hong Yun, et al.
Publicado: (2023)

Universal CARs, universal T cells, and universal CAR T cells
por: Zhao, Juanjuan, et al.
Publicado: (2018)

Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility
por: Celichowski, Piotr, et al.
Publicado: (2023)

Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma
por: Bughda, Reyisa, et al.
Publicado: (2021)

The Landscape of CAR-T Cell Clinical Trials against Solid Tumors—A Comprehensive Overview
por: Schaft, Niels
Publicado: (2020)

Recent advances in electroconvulsive therapy in clinical practice and research
por: Mukhtar, Fahad, et al.
Publicado: (2023)

Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology
por: Lontos, Konstantinos, et al.
Publicado: (2022)

CAR-T Cells Immunotherapies for the Treatment of Acute Myeloid Leukemia—Recent Advances
por: Zarychta, Julia, et al.
Publicado: (2023)

Journey of CAR T-cells: Emphasising the concepts and advancements in breast cancer (Review)
por: Kausar, Mohd Adnan, et al.
Publicado: (2023)

Recent Advances in CAR T-Cell Therapy for Patients with Chronic Lymphocytic Leukemia
por: Heyman, Benjamin M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_61ss7grks9q43mcckq1adjnbnk